 outcome
assessors. The studies reported on 5498 patients (mean
age, 70 years; 67% males) with a varying prevalence of
comorbidities (commonly coronary artery disease, hypertension, and hypercholesterolemia). Patients in all studies
received aggressive medical treatment following up-todate national and international guidelines. Those treatments were focused on antiplatelet therapy, antihypertensive therapy, and lipid-lowering therapy.
